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that several measures were dependent on movement around the maze it was 151 important to eliminate potential locomotor confounds. To address this issue, we 152 measured activity independently in a non-anxiety provoking environment and found 153 no group differences (Figure 3h ) indicating the EPM measures were not influenced by 154 movement confounds. 155
[ Figure 3 about here] 156
Next it was important to establish that the anxiety phenotype was not task-specific, i.e. 157 confined to a single behavioural task. Using a separate cohort of animals, we 158 assessed behaviour in the elevated zero maze (EZM), another established assay of 159 anxiety related-behaviour which differs from the EPM in the absence of a central zone, Figure 4d ). In contrast to the EPM, there was no difference 170 in head dips between the C3aR -/and wildtype animals, but again C3 -/mice performed 171 significantly more head dips (Figure 4f ). We carried out additional analyses in the open 172 field test of emotional reactivity and noted, consistent with the maze data, indices of 173 enhanced anxiety in the C3aR -/mice ( Supplementary Figure 2) . Finally, we observed 8 ( Supplementary Figure 1c ) that was present in all C3aR -/cohorts. Over-grooming has 176 been associated with enhanced stress and anxiety 23, 25 and has previously been linked 177 to the immune system and microglial dysfunction 30 . 178
[ Figure 4 about here] 179
Altered sensitivity of C3aR -/mice to diazepam in the elevated plus maze 180
In a separate cohort of animals we repeated the EPM experiment and in addition 181 (Figure 5c ), an effect often held to index reduced anxiety 24,32,33 , however these 191 effects did not reach statistical significance. In contrast, we did observe effects of 192 diazepam on SAPs, specifically a highly significant reduction in wildtype animals 193 consistent with the anticipated reduction in anxiety. This reduction in SAPs was 194 completely absent in C3aR -/mice ( Figure 5d ). Differences in the sensitivity of open 195 arm and ethological measures to benzodiazepines has been noted previously 26 and it 196 has been suggested that SAPs offer a more sensitive indication of anxiolysis 34 . 197 Locomotor activity monitored across all areas of the maze indicated that the drug 198 effects in wildtype and C3aR -/mice were unlikely to have been influenced by sedation 9 (Figure 5e ). In C3 -/mice however, activity was significantly suppressed under drug In a sub-cohort of wildtype, C3 -/and C3aR -/mice treated with vehicle in the diazepam 206 study, we assayed plasma corticosterone 30 minutes after exposure to the EPM and 207 compared levels to those of a group of animals who remained in their home-cages 208 (baseline condition). There were no genotype differences in basal levels of 209 corticosterone ( Figure 6 ), however, being placed on the EPM increased plasma 210 corticosterone 6-15 fold in all genotypes, suggesting that the EPM was a potent 211 stressor. Post hoc analyses indicated a significantly greater EPM-evoked 212 corticosterone response in the C3aR -/animals. Given the relationship between 213 behavioural indices of anxiogenesis and activation of the hypothalamic-pituitary 214 adrenal (HPA) axis 35, 36 , these data were consistent with the behavioural findings 215
showing markedly increased levels of unconditioned anxiety in the C3aR -/animals. 216
[ Figure 6 about here] 217
Administration of the C3aR antagonist SB290157 did not phenocopy C3aR -/-218 mice 219
The specific effects of C3aR knockout on unconditioned anxiety could have been due 220 to developmental changes leading to enduring effects on behaviour and/or effects 221 mediated acutely in the adult brain. To distinguish between these possibilities we 10 examined the extent to which systemic administration of the C3aR antagonist 223 SB290157 23 to wildtype mice at doses which have been shown to influence brain 224 phenotypes 5,37 would phenocopy C3aR -/mice. Two dosing regimens were used; a 225 single injection of SB290157 (i.p,10mg/kg) 60 minutes prior to testing on the EPM and 226 a chronic regime of twice daily injections (i.p, 10mg/kg) for 5 days with EPM testing 24 227 hours after the last treatment. Again, the finding of enhanced anxiety was replicated 228
in C3aR -/mice in both acute (Supplementary Figure 3 Enhanced conditioned fear in C3 -/but not C3aR -/mice 235
We next assessed the effects of C3/C3aR manipulations on conditioned, (i.e., learnt) 236 fear in a separate group of animals using the fear potentiated startle (FPS) 237 paradigm 38,39 . In the FPS task a conditioned stimulus (CS, in our case a 30sec light 238 stimulus previously associated with a mild foot shock) presented simultaneously with 239 a startle (pulse-alone) stimulus ( Figure 8a ) leads to an augmented or 'potentiated' 240 startle response. The index of learning is generated by the difference between the 241 startle response to pulse-alone trials relative to pulse+CS trials and is an established 242 means of assaying conditioned fear employed extensively in human and animal model 243 investigations of fear learning 40,41 . In the pre-conditioning session, pulse-alone trials 244 indicated increased basal startle reactivity in both C3aR -/and C3 -/animals relative to 245 wildtype ( Figure 8b) . Increased reactivity was also demonstrated by both knockouts 246 with regard to the effects of the unconditioned foot shock stimulus (in the absence of 247 any startle stimulus) during the conditioning session, as shown in Figure 8c . The 248 potentiation of the startle response by the CS in the post-conditioning session is 249 illustrated in Figure 8d . Here, in contrast to the previous assays of unconditioned 250 anxiety an opposite pattern of effects was observed, with C3 -/animals showing a 251 selective enhancement of conditioned fear relative to the C3aR -/and wildtype animals. 252
It is important to note that the enhanced fear learning in C3 -/mice was completely 253 dissociated and therefore not confounded by the underlying effects on basal startle 254 reactivity and/or sensitivity to the foot shock alone, since these effects were common 255 to both knockouts yet only C3 -/animals showed the effect on fear learning. These data 256
showing opposing effects of C3 -/and C3aR -/on innate anxiety-inducing stimuli and 257 learned anticipatory fear suggested differential impact of the knockouts on associated 258 brain circuitries. 259
[ Figure 8 about here] 260
No effects on conditioned fear in C6 -/mice 261
The demonstration of enhanced fear learning in C3 -/-, but not C3aR -/mice suggested 262 that the effects in C3 -/mice were mediated by molecules downstream of C3, 263 independent from C3a/C3aR. As C3 -/mice cannot activate complement beyond C3 264 and therefore lack terminal pathway (C6-C9) activation, it is possible that the indirect 265 loss of function of these molecules may contribute to the fear learning phenotype. We 266 therefore compared C3 -/with C6 -/mice and hypothesised that should C6 -/mice show 267 comparable behaviour to C3 -/mice then the phenotype would likely be due to a loss 268 of terminal pathway activity. On the other hand, if C6 -/mice demonstrated no fear 269 learning phenotype, this would confine the likely mediating molecules to either C3b or 12 the downstream protein C5 and its breakdown products. Using a separate cohort of 271 mice, we replicated the previous C3 -/finding ( Figure 9 ) demonstrating that relative to 272 wildtype mice, C3 -/mice showed enhanced basal startle responses (Figure 9a ), 273 increased reactivity to the foot shock alone ( Figure 9b ) and a significant enhancement 274 in conditioned fear ( Figure 9c ). However, across all these measures the C6 -/mice 275
were not different to wildtypes, a pattern of effects consistent with the involvement of 276
C3b/CR3 or C5a/C5aR signalling in the C3 -/phenotype. Additionally, we did not 277 observe any innate anxiety-like phenotypes in C6 -/mice ( Supplementary Figure 4) . 278
[ Figure 9 about here] 279
Discussion 280
We have used a number of in vivo knockout models manipulating specific complement 281 proteins to reveal dissociable effects on innate and conditioned emotional behaviours. 282
A main finding was a profound innate anxiety phenotype in the C3aR -/mice manifest 283 across independent behavioural tasks, and repeated assays, that was absent in the 284 C3 -/animals. The specificity of the anxiety phenotype exhibited by C3aR -/mice at the 285 behavioural level was paralleled by EPM-evoked corticosterone levels, confirming the 286 validity of the EPM as an index of anxiety. A second main finding was a double 287 dissociation in terms of learned fear. Here, using potentiated startle, we observed the 288 opposite pattern of effects whereby C3 -/and not C3aR -/mice displayed enhanced fear 289 reactivity to a conditioned light cue. Taken together, these data are strongly suggestive 290 of distinct functional effects mediated by closely related elements of the complement 291 system. The mechanistic basis of these distinct effects is unknown at present, but they 292 suggest fundamentally different impacts of C3 and C3aR signalling on the brain 293 mechanisms underlying innate anxiety and learned fear. 294 13 A major implication of our findings relates to the unexpected specificity of the effects 295 of C3aR on unconditioned anxiety and corticosterone levels. Since C3a can only be 296 produced via C3 cleavage and C3aR is the canonical receptor for C3a, a priori we 297 expected that any phenotypes dependent on the binding of C3a to C3aR would be 298 apparent in both C3 -/and C3aR -/models. Given the divergence in innate anxiety 299 observed, one explanation is that the C3aR -/phenotypes are C3a independent and 300 instead mediated by an alternative ligand. A potential molecular promiscuity of C3aR 301 arises from its long extracellular loop, unique among GPCRs 42 but so far, only one 302 alternative ligand has been identified, a cleavage fragment of the neuropeptide 303 precursor protein VGF (non-acronymic), TLQP-21 43,44 . This peptide has highly 304 pleiotropic roles including in the stress response 45 , though few of these roles have, to 305 date, been directly attributed to C3aR signalling. VGF is widely expressed throughout 306 the CNS with high levels found in the hypothalamus, a region associated with stress 307 reactivity and abundant C3aR expression 46,47 . Interestingly, there is further potential 308 for interaction between complement and TLQP-21 in that C3a stimulates nerve growth 309 factor (NGF) expression by glial cells 48 , which in turn triggers VGF synthesis, the 310 source of TLQP-21 49 . TLQP-21 may also bind the Complement component 1q 311 receptor, gC1qR 50 . TLQP-21 will therefore be an important target in future 312 investigations of the mechanistic basis of C3aR dependent anxiety phenotypes. 313
Evidence of elevated plasma corticosterone levels in C3aR -/mice after exposure to 314 the EPM, but not at baseline, suggests the anxiety phenotype observed corresponds 315 to 'state' rather than 'trait' anxiety. State anxiety occurs acutely and is enhanced by 316 anxiogenic stimuli, whereas trait anxiety is an enduring characteristic 51 . We were 317 interested in the stress response not only due to the inherent link between stress and 318 anxiety, but also due to the known synergy between the immune and endocrine 14 systems 52 . C3aR is expressed at particularly high levels in endocrine tissues and 320 dosing of C3a stimulates hormone secretion via C3aR 46,47 , suggesting it is highly likely 321 that the phenotypes observed in C3aR -/mice involve perturbations in the HPA axis. 322
We probed mechanisms underpinning the C3aR -/phenotype on innate anxiety by 323 assessing the effects of the anxiolytic diazepam on EPM behaviour. Under our test 324 conditions, measures of open arm exploration were insensitive to diazepam treatment 325 but there were specific effects on SAPs, whereby a dose of diazepam that was 326 anxiolytic (i.e., reduced SAPs) in wildtype mice had no effects in C3aR -/mice. SAPs 327 are highly sensitive to pharmacological manipulation 28,53 and in agreement with our 328 own findings, diazepam has been shown to specifically decrease SAPs in the absence 329
of effects on open arm exploration 54 . Importantly, C3aR -/mice consistently displayed 330 the greatest number of SAPs compared to other genotypes, and therefore the lack of 331 drug effects were not due to floor effects. Hence, we propose that SAPs constitute a 332 valid, sensitive index of drug action and that our findings of altered reactivity to 333 diazepam in the C3aR -/are most likely indicative of altered underlying neurobiology. 334
Since benzodiazepine action is dependent on GABAA receptor function 55 , the 335 expression of GABAA receptor subunits in C3aR -/mice would be a high priority for 336 future work. 337
Another question relating to potential mechanisms was whether anxiety phenotypes 338 seen in the C3aR -/mice were a result of acute, ongoing effects of C3aR deletion in 339 the adult brain or instead the consequence of neurodevelopmental impacts of C3aR 340 deficiency. At the outset, both were possibilities on the basis of previous findings 341
implicating C3aR in developmental neurogenesis 56 and acute changes in C3aR 342 expression in the adult brain after behavioural manipulations 57 . The C3aR antagonist 15 used and hence the data were most consistent with C3aR knockout influencing adult 345 behaviour via developmental mechanisms, resulting in enduring effects in the adult 346 brain. It should be noted that SB290157 has attracted criticism due to evidence 347 suggesting agonist activity at certain doses and in particular cell types 58 . However, the 348 negative results seen here were not consistent with agonist effects, which one may 349 hypothesize would lead to reduced anxiety in the EPM. 350
Previously, aged C3 -/mice have been reported to demonstrate less anxiety in the 351 EPM 8 . While we did not test aged mice, we did observe a subtle anxiolytic effect of C3 352 deficiency. In maze-based tasks, C3 -/mice consistently performed the greatest 353 number of head dips, and the least SAPs. We also saw a trend towards increased 354 open arm exploration (see Figure 4c , d and vehicle-treated C3 -/mice in Figure 5c It is possible that these effects would be more pronounced if aged animals had been 357 tested, and again suggests opposing effects of C3 and C3aR knockout on innate 358 anxiety. However, we also observed an anxiogenic effect of C3 -/on baseline acoustic 359 startle responses ( Figure 8b ), a phenotype that was shared with C3aR -/mice. While 360 it may be expected that animals displaying greater anxiety-like behaviour in a maze-361 based task may also display enhanced baseline startle reactivity, as seen in C3aR -/-362 mice, a disconnect between exploration-based tasks and startle responses has been 363 reported in rats selectively bred for low or high-anxiety like behaviour 59 . Our results 364 suggest that C3 may have differential effects upon brain circuitries that mediate 365 approach/avoidance behaviours versus those that mediate reflexes such as the startle 366
response. 367
In contrast to innate anxiety, we observed a specific effect of C3 knockout in regard to 368 conditioned fear. Lack of a comparable phenotype in C6 -/mice confirmed that the 369 16 effects were independent of terminal pathway activation and membrane attack 370 complex formation (see Figure 1) . Similarly, the lack of effects in C3aR -/mice relative 371 to wildtype indicated that the phenotype was unlikely to be C3a/C3aR dependent. 372
These observations lead to three possibilities regarding the mediating pathways. 373
Firstly, effects could be mediated via altered C3b/CR3 dependent synaptic 374 elimination 3,4 , suggesting a developmental mechanism. In support, complement 375 mediated synaptic pruning has now been demonstrated in brain regions relevant to 376 fear learning such as the amygdala 60 and alterations in glutamatergic synapses within 377 the hippocampus have been reported in C3 -/mice 61 . The C3b/ CR3 pathway could 378 also be involved acutely in learning within the adult brain, as C3 mRNA is upregulated 379 during discrete stages of fear learning 57 and microglial CR3 is implicated in long term 380 depression 62 . The second possibility is that C5a/C5aR, which have a range of 381 developmental roles 56 , mediate enhanced fear-learning phenotypes in C3 -/mice, 382
although there is less evidence currently for a role of C5a/C3aR in this realm. As a 383 third possibility, there is also evidence for interaction between C3a breakdown product 384 (C3aDesArg) and C5L2, a receptor sharing similar sequence homology with C5aR and 385
C3aR whose function has not yet been fully elucidated 63 . Further investigation of the 386 signalling pathways contributing to the conditioned fear phenotype will be a priority for 387 future research. It will also be necessary to determine whether the phenotype applies 388 to aversive stimuli specifically or whether C3 -/mice show enhanced learning generally, 389
irrespective of motivation. 390
The functional consequences of complement are dependent on the location of 391 complement activation and receptor expression. Whether differential expression of C3 392
and C3aR in the brain circuitries and cell types underlying innate anxiety and learned 393 fear contribute to the behavioural dissociations we observe is difficult to ascertain at 394 present. C3aR is expressed primarily by neurons but is also found in astrocytes, 395 microglia and oligodendrocytes 64,65 and C3 is synthesized by most cell types at low 396 constitutive levels throughout the CNS 66,67 . The neural substrates of innate anxiety 397 behaviours overlap to an extent with learned fear circuits 68 . Given there is currently no 398 systematic data comparing and contrasting C3 with C3aR expression across these 399 circuits, an unbiased approach may be the most immediately informative. For 400 example, neuronal activity markers such as immediate early genes could be used to 401 assess circuit and cellular activation, at baseline and subsequent to aversive challenge 402 in C3 -/and C3aR -/mice, where the prediction would be that the patterns of activation 403 would be different in the two models despite exposure to identical aversive stimuli. 404
While our experiments using C3 -/and C3aR -/mouse models have focused on aspects 405 of anxiety and learned fear, these endophenotypes are commonly comorbid with 406 depression, and recent work has suggested a role for C3a/C3aR in the 407 pathophysiology of major depressive disorder resulting from chronic stress 69 . Given 408 the common co-occurrence of anxiety and depression, our findings of enhanced 409 anxiety in C3aR -/mice might seem at odds with the reported resilience of C3aR -/mice 410 to chronic-stress induced depressive behaviour 69 . However, Crider et al (2018) used 411 a chronic unpredictable-stress paradigm 69 likely to evoke significant inflammation, and 412 therefore the extent to which our data in acutely stressed animals can be compared is 413
Finally, it is of interest to consider the degree to which our findings relate to the genetic 415 data implicating C4 in the pathogenesis of schizophrenia 14 . The C4 variants identified 416 were predicted to increase C4 expression and therefore increase activation of C3 15 , 417 and thus our data from C3 -/mice is not immediately applicable. Nonetheless, it is 418 possible that both excessive or reduced complement activation could lead to 419 dysfunction, implicating complement as a potential mediator of abnormal fear learning 420 in schizophrenia 70 . Similarly, it is difficult at present to draw links between C4 and our 421 results demonstrating a role of C3aR in innate anxiety, firstly because of the 422 independence of the phenotype to C3 signalling and secondly due to the current lack 423 of data linking other elements of the complement system beyond C4 to psychiatric (generated from a speaker 120 mm above the cylinder) were recorded via a 741 piezoelectric accelerometer, attached centrally below the Plexiglas cylinder, which 742 converted flexion plinth vibration into electrical signals 73 . The peak startle response, 743 within 200ms from the onset of each startle presentation, in each trial, was normalized 744 8a). On the first day, mice were given a pre-conditioning session immediately followed 750 by the conditioning session. The pre-conditioning session started with a 5 min 751 acclimatisation phase followed by presentation of 3 no-stimulus trials, and then a block 752 of pulse-alone trials presented at 90, 100 and 110dB (5 of each at 40 ms duration). 753
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counterbalanced between the two test conditions and throughout the testing period. fragment C3a, which binds to its canonical receptor C3aR, a member of the GPCR 849 superfamily, characterised by seven transmembrane domains and a large second 850 extracellular loop. This signaling pathway is preserved in wildtype (WT) mice, whereas 851 homozygous C3 knockout mice lack a functional C3 molecule. Therefore, C3 cannot 852 be cleaved by C3 convertase and thus complement cannot be activated beyond C3, 853
and C3a cannot be generated. While C3 -/mice have a functional C3aR, there is no 854
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